Although the mortality rate of STAD is showing a decreasing trend, the 5-year survival of patients with advanced STAD is still below 30% ( 5 ).
← all excerpts
N6-Methyladenosine Regulators Promote Malignant Progression of Gastric Adenocarcinoma.
1
—
—